New York, NY, United States of America

Kemal Akat

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Rockefeller University. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kemal Akat: Innovator in RNA Isolation Techniques

Introduction

Kemal Akat is a notable inventor based in New York, NY (US). He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid isolation. His innovative methods have the potential to enhance research and clinical applications.

Latest Patents

Kemal Akat holds a patent for a "Method of RNA isolation from clinical samples." This patent discloses methods for isolating nucleic acids from biological fluids. One aspect of the disclosure provides a method specifically for isolating RNA, while another aspect focuses on isolating DNA. The methods utilize a protocol that combines detergent-based initial denaturation, protease digestion, and organic extraction, followed by column purification. This approach maximizes RNA and DNA yield while preserving their integrity. Additionally, the patent includes a kit designed for isolating RNA and/or DNA.

Career Highlights

Kemal Akat is affiliated with The Rockefeller University, where he conducts his research and development work. His position at this prestigious institution allows him to collaborate with leading scientists and contribute to groundbreaking discoveries in the field of genetics.

Collaborations

Some of his coworkers include Klaas Max and Karl Bertram. Their collaborative efforts likely enhance the research environment and foster innovation within their projects.

Conclusion

Kemal Akat's work in RNA isolation represents a significant advancement in molecular biology techniques. His contributions are poised to impact both research and clinical practices positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…